Evidence map›Paper›PMID 39673303›Full record

ArticlePhysiologia plantarum

β-aminobutyric acid does not induce defenses or increase Norway spruce resistance to the bluestain fungus Grosmannia penicillata.

Ngan Bao Huynh, Paal Krokene, Line Nybakken, Vytautas Čėsna, Melissa H Mageroy

Abstract read
In one paragraph

Article in Physiologia plantarum. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ngan Bao HuynhDivision of Biotechnology and Plant Health, Norwegian Institute of Bioeconomy Research, Ås, Norway.
Paal KrokeneDivision of Biotechnology and Plant Health, Norwegian Institute of Bioeconomy Research, Ås, Norway.
Line NybakkenFaculty of Environmental Sciences and Natural Resource Management, Norwegian University of Life Sciences, Ås, Norway.
Vytautas ČėsnaInstitute of Forestry, Lithuanian Research Centre for Agriculture and Forestry, Girionys, Lithuania.
Melissa H MageroyDivision of Biotechnology and Plant Health, Norwegian Institute of Bioeconomy Research, Ås, Norway.ORCID https://orcid.org/0000-0001-7801-1007

Funding

Norges Forskningsråd 249958Norges Forskningsråd 324129
6 · The paper itself

Abstract

Priming of Norway spruce (Picea abies) inducible defenses is a promising way to protect young trees from herbivores and pathogens. Methyl jasmonate (MeJA) application is known to induce and potentially prime Norway spruce defenses but may also reduce plant growth. Therefore, we tested β-aminobutyric acid (BABA) as an alternative priming chemical to enhance spruce resistance, using 2-year-old Norway spruce plants. We compared inducible defense responses, i.e. traumatic resin duct formation and accumulation of defensive metabolites, in bark and xylem tissues of BABA- or MeJA-treated plants before and after wounding. We also evaluated the effect of these chemical treatments on Norway spruce resistance to the pathogenic bluestain fungus Grosmania penicilliata. BABA did not induce defense responses or pathogen resistance, it even reduced concentrations of total terpenes in the treated plants. In contrast, MeJA induced traumatic resin duct formation, accumulation of flavonoids, pathogen resistance, and did not affect plant growth. For the first time, flavan-3-ols (catechins) were shown to have a primed response to MeJA treatment in Norway spruce. Our results indicated that BABA is not a suitable alternative priming chemical to MeJA in Norway spruce.

Indexed as

AcetatesAminobutyratesAscomycotaCyclopentanesDisease ResistanceOxylipinsPiceaPlant DiseasesFlavonoidsPlant BarkXylem3-aminobutyric acidAcetatesAminobutyratesCyclopentanesFlavonoidsmethyl jasmonateOxylipins

Identifiers

PMID39673303
PMCPMC11645543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.